tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ZVSA Stock Latest News

Zyversa Therapeutics Faces Financial Challenges Amid Drug Development
Company AnnouncementsZyversa Therapeutics Faces Financial Challenges Amid Drug Development
17d ago
ZVSA
ZyVersa Therapeutics Delays 10-Q Filing
PremiumCompany Announcements
ZyVersa Therapeutics Delays 10-Q Filing
22d ago
ZVSA
Zyversa Therapeutics’ Promising Phase 2a Study on DKD Treatment
PremiumCompany Announcements
Zyversa Therapeutics’ Promising Phase 2a Study on DKD Treatment
1M ago
ZVSA
ZyVersa Therapeutics Faces Nasdaq Delisting Notice
PremiumCompany Announcements
ZyVersa Therapeutics Faces Nasdaq Delisting Notice
3M ago
8K
ZVSA
ZyVersa Therapeutics highlights publication of data on inflammasome inhibitors
PremiumThe Fly
ZyVersa Therapeutics highlights publication of data on inflammasome inhibitors
3M ago
ZVSA
ZyVersa Therapeutics highlights lipidomic data in Alport Syndrome, DKD
PremiumThe FlyZyVersa Therapeutics highlights lipidomic data in Alport Syndrome, DKD
3M ago
ZVSA
ZyVersa Therapeutics Reports Financial Challenges Amid Nasdaq Delisting
Premium
Company Announcements
ZyVersa Therapeutics Reports Financial Challenges Amid Nasdaq Delisting
4M ago
ZVSA
ZyVersa Therapeutics highlights data on role of lipotoxicity in DKD
Premium
The Fly
ZyVersa Therapeutics highlights data on role of lipotoxicity in DKD
4M ago
ZVSA
ZyVersa Therapeutics reports Q2 EPS (46c) vs. ($3.31) last year
PremiumThe Fly
ZyVersa Therapeutics reports Q2 EPS (46c) vs. ($3.31) last year
4M ago
ZVSA
ZyVersa Therapeutics expects cash to fund requirements on month-to-month basis
PremiumThe Fly
ZyVersa Therapeutics expects cash to fund requirements on month-to-month basis
4M ago
ZVSA
ZyVersa Therapeutics Stock Approved for OTCQB Listing
PremiumCompany Announcements
ZyVersa Therapeutics Stock Approved for OTCQB Listing
4M ago
8K
ZVSA
ZyVersa CEO says ‘deeply committed’ to executing with discipline, urgency
PremiumThe Fly
ZyVersa CEO says ‘deeply committed’ to executing with discipline, urgency
5M ago
ZVSA
ZyVersa Therapeutics Faces Nasdaq Delisting, Plans Pink Market Move
PremiumCompany AnnouncementsZyVersa Therapeutics Faces Nasdaq Delisting, Plans Pink Market Move
5M ago
8K
ZVSA
ZyVersa Therapeutics Enters Warrant Exercise Agreement
Premium
Company Announcements
ZyVersa Therapeutics Enters Warrant Exercise Agreement
5M ago
8K
ZVSA
ZyVersa announces warrant inducement transaction for $2M in gross proceeds
Premium
The Fly
ZyVersa announces warrant inducement transaction for $2M in gross proceeds
5M ago
ZVSA
ZyVersa supports FDA-authorized Emergency Compassionate Use of VAR 200
PremiumThe Fly
ZyVersa supports FDA-authorized Emergency Compassionate Use of VAR 200
5M ago
ZVSA
ZyVersa Therapeutics files to sell 17.5M shares of common stock for holders
PremiumThe Fly
ZyVersa Therapeutics files to sell 17.5M shares of common stock for holders
5M ago
ZVSA
ZyVersa announces first clinical site activation in VAR 200 Phase 2a trial
PremiumThe Fly
ZyVersa announces first clinical site activation in VAR 200 Phase 2a trial
5M ago
ZVSA
ZyVersa Therapeutics Secures $10M Equity Purchase Agreement
PremiumCompany Announcements
ZyVersa Therapeutics Secures $10M Equity Purchase Agreement
5M ago
8K
ZVSA
ZyVersa Therapeutics announcs share purchase agreement for up to $10M
PremiumThe FlyZyVersa Therapeutics announcs share purchase agreement for up to $10M
5M ago
ZVSA
ZyVersa Therapeutics Stockholders Approve Key Proposals
Premium
Company Announcements
ZyVersa Therapeutics Stockholders Approve Key Proposals
6M ago
8K
ZVSA
ZyVersa Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
ZyVersa Therapeutics Reports Q1 2025 Financial Results
6M ago
ZVSA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >